173 related articles for article (PubMed ID: 12562311)
1. Anti-cocaine vaccines: antibody protection against relapse.
Kantak KM
Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
[TBL] [Abstract][Full Text] [Related]
2. Cocaine vaccines: antibody protection against relapse in a rat model.
Carrera MR; Ashley JA; Zhou B; Wirsching P; Koob GF; Janda KD
Proc Natl Acad Sci U S A; 2000 May; 97(11):6202-6. PubMed ID: 10823960
[TBL] [Abstract][Full Text] [Related]
3. Vaccines against drugs of abuse: a viable treatment option?
Kantak KM
Drugs; 2003; 63(4):341-52. PubMed ID: 12558457
[TBL] [Abstract][Full Text] [Related]
4. Vaccines against stimulants: cocaine and MA.
Kosten T; Domingo C; Orson F; Kinsey B
Br J Clin Pharmacol; 2014 Feb; 77(2):368-74. PubMed ID: 23509915
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against drug abuse.
Shen XY; Orson FM; Kosten TR
Clin Pharmacol Ther; 2012 Jan; 91(1):60-70. PubMed ID: 22130115
[TBL] [Abstract][Full Text] [Related]
6. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.
Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R
J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320
[TBL] [Abstract][Full Text] [Related]
7. Is immunotherapy an opportunity for effective treatment of drug addiction?
Zalewska-Kaszubska J
Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic vaccines for substance dependence.
Kosten TR; Biegel D
Expert Rev Vaccines; 2002 Oct; 1(3):363-71. PubMed ID: 12901575
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic vaccines for substance dependence.
Haney M; Kosten TR
Expert Rev Vaccines; 2004 Feb; 3(1):11-8. PubMed ID: 14761239
[TBL] [Abstract][Full Text] [Related]
10. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.
Hall W; Carter L
J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512
[TBL] [Abstract][Full Text] [Related]
11. Vaccine pharmacotherapy for the treatment of cocaine dependence.
Martell BA; Mitchell E; Poling J; Gonsai K; Kosten TR
Biol Psychiatry; 2005 Jul; 58(2):158-64. PubMed ID: 16038686
[TBL] [Abstract][Full Text] [Related]
12. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
[TBL] [Abstract][Full Text] [Related]
13. Anti-drug vaccines to treat substance abuse.
Kinsey BM; Jackson DC; Orson FM
Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250
[TBL] [Abstract][Full Text] [Related]
14. Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.
Koob G; Hicks MJ; Wee S; Rosenberg JB; De BP; Kaminsky SM; Moreno A; Janda KD; Crystal RG
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):899-904. PubMed ID: 22229312
[TBL] [Abstract][Full Text] [Related]
15. Hapten optimization for cocaine vaccine with improved cocaine recognition.
Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for cocaine abuse.
Orson FM; Kinsey BM; Singh RA; Wu Y; Kosten TR
Hum Vaccin; 2009 Apr; 5(4):194-9. PubMed ID: 19276665
[TBL] [Abstract][Full Text] [Related]
17. Development of a therapeutic vaccine for the treatment of cocaine addiction.
Fox BS
Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013
[TBL] [Abstract][Full Text] [Related]
18. [Vaccines against substance abuse].
Mørland J
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2974-6. PubMed ID: 17117198
[No Abstract] [Full Text] [Related]
19. Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
Havlicek DF; Rosenberg JB; De BP; Hicks MJ; Sondhi D; Kaminsky SM; Crystal RG
PLoS One; 2020; 15(11):e0239780. PubMed ID: 33253224
[TBL] [Abstract][Full Text] [Related]
20. DBH gene as predictor of response in a cocaine vaccine clinical trial.
Kosten TR; Domingo CB; Hamon SC; Nielsen DA
Neurosci Lett; 2013 Apr; 541():29-33. PubMed ID: 23458673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
